HC

Honasa Consumer Ltd

Q4 FY26Personal Products

Honasa Consumer Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹482
Market cap₹15.0K Cr
P/E73.6
Updated23 Aug 2026
Read5 min read

The short version

Honasa Consumer Limited expects to grow at a high-teens CAGR over the next 5 years. Honasa plans a high-teens CAGR growth over the next 5 years. - The company aims to improve its EBITDA margin by 500 basis points over the same period. - Annual EBITDA expansion target is about 100 basis points per year. - Mamaearth is expected to grow at a double-digit CAGR over the next 5 years. - Younger brands are growing strongly, with growth rates near 40% including acquisitions. - The focus categories, receiving over 90% of investment, are expected to continue driving growth. - Margins for core brands like Mamaearth and Derma Co.

From Honasa Consumer Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Honasa Consumer Limited expects to grow at a high-teens CAGR over the next 5 years.
  • Annual EBITDA margin improvement target is approximately 100 basis points per year, totaling a 500 basis points expansion over 5 years.
  • Young brands are expected to continue driving strong growth at high levels.
  • Focus categories receive over 90% of investment and are anticipated to be key growth drivers.
  • Mamaearth aims for a double-digit CAGR over the next 5 years, with potential to increase distribution from 200,000 to 0.5 million outlets.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Honasa Consumer Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The company is focused on investing in talent, as evidenced by recent key appointments including a CEO with cosmetics and makeup experience, a nutraceutical founder, and other experts to build new businesses and shape future growth horizons.
  • Strategic investments are made in expanding distribution, especially for acquired brands like Reginald Men, where efforts to scale distribution across platforms like e-commerce channels (e.g., Nykaa) and new geographies (such as Maharashtra) are underway.
  • There is a focus on category expansion and innovation, investing in R&D and new product launches to enter new partitions and take structural market share.

2 more points management made on capital expenditure plans

Top-ranked in Personal Products

Ranked on what management guided this quarter

5x potential
1Anondita Medi.
Rev 1Mar 1
2Godrej Consumer
Rev 3Mar 3
3
Rev 3Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Honasa Consumer Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The provided transcript of Honasa Consumer Limited's Q4 and FY26 earnings call does not specifically mention any details about the company's current or expected order book or pending orders. The discussion primarily focuses on: - Financial performance (revenue growth, EBITDA, PAT) - Brand growth and strategies (Mamaearth, Derma Co., Reginald Men) - Channel and category focus - Margin expansion and premiumization strategy

2 more points management made on order book & pipeline

Honasa Consumer Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹608 Cr, net profit ₹64 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Personal Products this season

  • Anondita Medicare Ltd (Q4 FY26)

    Current unexecuted order book stands at approximately INR137 crores, which remains intact from the previous year. Key concall takeaways from Anondita Medicare…

  • Cupid Ltd (Q4 FY26)

    Q4 FY26 Revenue from operations: ₹119.96 Cr, up 112.39% YoY from ₹56.48 Cr in Q4 FY25 (Page 18). Key concall takeaways from Cupid Ltd's Q4 FY26 earnings call…

  • Bajaj Consumer Care Ltd (Q4 FY26)

    Revenue growth momentum is strong, with a 21% increase for the full year FY26 and a 30% top-line growth noted in Q4. Key concall takeaways from Bajaj Consumer…

  • Godrej Consumer (Q4 FY26)

    Operating metrics such as ARR for Fab portfolio (~INR 500 crores GSV). Key concall takeaways from Godrej Consumer's Q4 FY26 earnings call — and how it ranks…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Honasa Consumer Ltd Q4 FY26 results?

Honasa Consumer Limited expects to grow at a high-teens CAGR over the next 5 years. Honasa plans a high-teens CAGR growth over the next 5 years. - The company aims to improve its EBITDA margin by 500 basis points over the same period. - Annual EBITDA expansion target is about 100 basis points per year. - Mamaearth is expected to grow at a double-digit CAGR over the next 5 years. - Younger brands are growing strongly, with growth rates near 40% including acquisitions. - The focus categories, receiving over 90% of investment, are expected to continue driving growth. - Margins for core brands like Mamaearth and Derma Co.

What is Honasa Consumer Ltd share price analysis?

Honasa Consumer Ltd currently shows a neutral. The stock trades at a P/E of 73.6 with a market cap of ₹14,986 Cr. Investors should review the full earnings analysis for detailed insights.

Is Honasa Consumer Ltd planning capital expenditure?

The company is focused on investing in talent, as evidenced by recent key appointments including a CEO with cosmetics and makeup experience, a nutraceutical founder, and other experts to build new businesses and shape future growth horizons.

Keep Honasa Consumer Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.